Andres Mauricio Arias-Lorza1 and Natarajan Raghunand1
1Moffitt Cancer Center, Tampa, FL, United States
1Moffitt Cancer Center, Tampa, FL, United States
ADC decreases in solid tumors following monotherapy with PEGylated Recombinant Human Hyaluronidase PEGPH20.
Figure 4. ADC changes in
muscle tissue (top) and Bland-Altman plot of ADC repeats differences at muscle.
Figure 3. Bland-Altman plot describing median ADC
repeatability. Each marker/color represents a baseline repeat difference at
each tumor. RC obtained per tumor is used to distinguish true changes in that
tumor. In case the patient does not have more than one repeat at baseline, the
full data RC given by the dashed lines is used instead.